Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Buy
105
+20
+24% +$1.98K ﹤0.01% 572
2026
Q1
$8K Sell
85
-5
-6% -$499 ﹤0.01% 550
2025
Q4
$8K Sell
90
-2
-2% -$194 ﹤0.01% 546
2025
Q3
$7K Hold
92
﹤0.01% 572
2025
Q2
$6K Buy
92
+38
+70% +$2.41K ﹤0.01% 582
2025
Q1
$3K Hold
54
﹤0.01% 645
2024
Q4
$3K Hold
54
﹤0.01% 643
2024
Q3
$3K Buy
54
+8
+17% +$510 ﹤0.01% 614
2024
Q2
$2K Buy
46
+36
+360% +$2.04K ﹤0.01% 619
2024
Q1
$1K Hold
10
﹤0.01% 978
2023
Q4
$1K Sell
10
-14
-58% -$792 ﹤0.01% 832
2023
Q3
$1K Sell
24
-8
-25% -$504 ﹤0.01% 654
2023
Q2
$1K Buy
32
+23
+256% +$1.54K ﹤0.01% 590
2023
Q1
$0 Buy
+9
New +$704 ﹤0.01% 649

Other funds holding INCY

Avion Wealth's INCY Position: Q2 2026 in Review

Avion Wealth increased its Incyte (INCY) stake by 24% in Q2 2026, buying an estimated $1.98K and bringing the position to 105 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Avion Wealth first reported a position in INCY in Q1 2023 and has held it in 14 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Avion Wealth held 105 shares of Incyte worth $11K as of Q2 2026.
  • Avion Wealth bought 20 Incyte shares in Q2 2026, an estimated $1.98K.
  • Incyte made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #572 holding.
  • Avion Wealth first reported a position in Incyte in Q1 2023 and has held it in 14 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.